353 related articles for article (PubMed ID: 27702752)
1. Emerging data on androgen receptor splice variants in prostate cancer.
Cao S; Zhan Y; Dong Y
Endocr Relat Cancer; 2016 Dec; 23(12):T199-T210. PubMed ID: 27702752
[TBL] [Abstract][Full Text] [Related]
2. The cistrome and gene signature of androgen receptor splice variants in castration resistant prostate cancer cells.
Lu J; Lonergan PE; Nacusi LP; Wang L; Schmidt LJ; Sun Z; Van der Steen T; Boorjian SA; Kosari F; Vasmatzis G; Klee GG; Balk SP; Huang H; Wang C; Tindall DJ
J Urol; 2015 Feb; 193(2):690-8. PubMed ID: 25132238
[TBL] [Abstract][Full Text] [Related]
3. Androgen receptor splice variant 7 in castration-resistant prostate cancer: Clinical considerations.
Bryce AH; Antonarakis ES
Int J Urol; 2016 Aug; 23(8):646-53. PubMed ID: 27255944
[TBL] [Abstract][Full Text] [Related]
4. Role of androgen receptor splice variants, their clinical relevance and treatment options.
Wach S; Taubert H; Cronauer M
World J Urol; 2020 Mar; 38(3):647-656. PubMed ID: 30659302
[TBL] [Abstract][Full Text] [Related]
5. The link between androgen receptor splice variants and castration-resistant prostate cancer.
Sprenger CC; Plymate SR
Horm Cancer; 2014 Aug; 5(4):207-17. PubMed ID: 24798453
[TBL] [Abstract][Full Text] [Related]
6. Predicting treatment response in castration-resistant prostate cancer: could androgen receptor variant-7 hold the key?
Antonarakis ES
Expert Rev Anticancer Ther; 2015 Feb; 15(2):143-5. PubMed ID: 25547524
[TBL] [Abstract][Full Text] [Related]
7. Isoform-specific Activities of Androgen Receptor and its Splice Variants in Prostate Cancer Cells.
Nagandla H; Robertson MJ; Putluri V; Putluri N; Coarfa C; Weigel NL
Endocrinology; 2021 Mar; 162(3):. PubMed ID: 33300995
[TBL] [Abstract][Full Text] [Related]
8. Androgen Receptor Splice Variants Dimerize to Transactivate Target Genes.
Xu D; Zhan Y; Qi Y; Cao B; Bai S; Xu W; Gambhir SS; Lee P; Sartor O; Flemington EK; Zhang H; Hu CD; Dong Y
Cancer Res; 2015 Sep; 75(17):3663-71. PubMed ID: 26060018
[TBL] [Abstract][Full Text] [Related]
9. Raddeanin A down-regulates androgen receptor and its splice variants in prostate cancer.
Xia H; Hu C; Bai S; Lyu J; Zhang BY; Yu X; Zhan Y; Zhao L; Dong Y
J Cell Mol Med; 2019 May; 23(5):3656-3664. PubMed ID: 30905075
[TBL] [Abstract][Full Text] [Related]
10. ZFX Mediates Non-canonical Oncogenic Functions of the Androgen Receptor Splice Variant 7 in Castrate-Resistant Prostate Cancer.
Cai L; Tsai YH; Wang P; Wang J; Li D; Fan H; Zhao Y; Bareja R; Lu R; Wilson EM; Sboner A; Whang YE; Zheng D; Parker JS; Earp HS; Wang GG
Mol Cell; 2018 Oct; 72(2):341-354.e6. PubMed ID: 30270106
[TBL] [Abstract][Full Text] [Related]
11. Growth Inhibition by Testosterone in an Androgen Receptor Splice Variant-Driven Prostate Cancer Model.
Nakata D; Nakayama K; Masaki T; Tanaka A; Kusaka M; Watanabe T
Prostate; 2016 Dec; 76(16):1536-1545. PubMed ID: 27473672
[TBL] [Abstract][Full Text] [Related]
12. Androgen receptor variant-driven prostate cancer II: advances in laboratory investigations.
Lu C; Brown LC; Antonarakis ES; Armstrong AJ; Luo J
Prostate Cancer Prostatic Dis; 2020 Sep; 23(3):381-397. PubMed ID: 32139878
[TBL] [Abstract][Full Text] [Related]
13. Blood Based Detection of Androgen Receptor Splice Variants in Patients with Advanced Prostate Cancer.
Antonarakis ES; Luo J
J Urol; 2016 Dec; 196(6):1606-1607. PubMed ID: 27620214
[No Abstract] [Full Text] [Related]
14. Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor.
Watson PA; Chen YF; Balbas MD; Wongvipat J; Socci ND; Viale A; Kim K; Sawyers CL
Proc Natl Acad Sci U S A; 2010 Sep; 107(39):16759-65. PubMed ID: 20823238
[TBL] [Abstract][Full Text] [Related]
15. Minnelide Inhibits Androgen Dependent, Castration Resistant Prostate Cancer Growth by Decreasing Expression of Androgen Receptor Full Length and Splice Variants.
Isharwal S; Modi S; Arora N; Uhlrich C; Giri B; Barlass U; Soubra A; Chugh R; Dehm SM; Dudeja V; Saluja A; Banerjee S; Konety B
Prostate; 2017 May; 77(6):584-596. PubMed ID: 28144973
[TBL] [Abstract][Full Text] [Related]
16. A positive role of c-Myc in regulating androgen receptor and its splice variants in prostate cancer.
Bai S; Cao S; Jin L; Kobelski M; Schouest B; Wang X; Ungerleider N; Baddoo M; Zhang W; Corey E; Vessella RL; Dong X; Zhang K; Yu X; Flemington EK; Dong Y
Oncogene; 2019 Jun; 38(25):4977-4989. PubMed ID: 30820039
[TBL] [Abstract][Full Text] [Related]
17. Androgen Receptor Splice Variants Are Not Substrates of Nonsense-Mediated Decay.
Ajiboye AS; Esopi D; Yegnasubramanian S; Denmeade SR
Prostate; 2017 Jun; 77(8):829-837. PubMed ID: 28224650
[TBL] [Abstract][Full Text] [Related]
18. Novel Selective Agents for the Degradation of Androgen Receptor Variants to Treat Castration-Resistant Prostate Cancer.
Ponnusamy S; Coss CC; Thiyagarajan T; Watts K; Hwang DJ; He Y; Selth LA; McEwan IJ; Duke CB; Pagadala J; Singh G; Wake RW; Ledbetter C; Tilley WD; Moldoveanu T; Dalton JT; Miller DD; Narayanan R
Cancer Res; 2017 Nov; 77(22):6282-6298. PubMed ID: 28978635
[TBL] [Abstract][Full Text] [Related]
19. Targeting Androgen Receptor Aberrations in Castration-Resistant Prostate Cancer.
Sharp A; Welti J; Blagg J; de Bono JS
Clin Cancer Res; 2016 Sep; 22(17):4280-2. PubMed ID: 27330057
[TBL] [Abstract][Full Text] [Related]
20. Interplay between Cytoplasmic and Nuclear Androgen Receptor Splice Variants Mediates Castration Resistance.
Zhan Y; Zhang G; Wang X; Qi Y; Bai S; Li D; Ma T; Sartor O; Flemington EK; Zhang H; Lee P; Dong Y
Mol Cancer Res; 2017 Jan; 15(1):59-68. PubMed ID: 27671337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
